nicorandil has been researched along with Diabetic Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Ling, M; Liu, C; Wang, Z; Xing, Y; Zhang, H; Zhang, M | 1 |
| An, F; Jin, T; Li, X; Liu, D; Liu, M; Pan, J; Tian, J; Wang, X; Zhang, M | 1 |
2 other study(ies) available for nicorandil and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Myocardial Protective Effects of Nicorandil on Rats with Type 2 Diabetic Cardiomyopathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Heart; Male; Malondialdehyde; Myocardium; Nicorandil; Rats; Rats, Wistar; Superoxide Dismutase | 2018 |
Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway.
Topics: Animals; Apoptosis; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Myocardium; Myocytes, Cardiac; Nicorandil; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin | 2019 |